1 min read

Real-world Evidence (RWE) is data collected from real-world healthcare settings, rather than from controlled clinical trials. This data can come from various sources, including electronic health records (EHRs), claims databases, patient registries, etc. Unlike traditional clinical trials, RWE provides insights into how medical products perform in everyday practice.

The Importance of RWE

  • Complements Clinical Trial Data: RWE can supplement information gathered from clinical trials by providing data on a larger and more diverse patient population.
  • Real-World Effectiveness: It helps assess how well a treatment works in real-world conditions, including patients with multiple health conditions.
  • Patient Outcomes: RWE can be used to track patient outcomes over time, identifying potential side effects or long-term benefits.
  • Drug Safety Monitoring: By analysing RWE, healthcare providers can identify potential safety concerns and monitor drug performance in the market.
  • Value-Based Care: RWE supports the shift towards value-based care by providing evidence on the cost-effectiveness of treatments.

Challenges and Opportunities

While RWE offers significant potential, there are challenges to overcome. Data quality, standardization, and privacy concerns are key issues. However, advancements in technology are helping to address these challenges.

RWE presents a vast opportunity for the pharmaceutical industry to optimize drug development, improve patient care, and demonstrate the value of their products.

Do you want to explore more about RWE? Get in touch with Freyr today!